What You Should Know:
– BrightInsight, Inc., a provider of regulated digital health solutions, has announced an expanded multi-year partnership with Sanofi, a global biopharmaceutical company. This expanded partnership builds on a successful collaboration that…
Continue Reading
What You Should Know:
– ConcertAI and NeoGenomics (NASDAQ: NEO) announce a joint software-as-a-service solution in hematological malignancies for research analytics, clinical trial design, and clinical trial operational optimization.
– CTO-H provides a research data solution that is…
Continue Reading
What You Should Know:
– GeneDx, a leader in genomic insights, has announced the launch of GeneDx Discover, a groundbreaking data visualization tool designed to revolutionize drug discovery and development.
– The platform provides biopharmaceutical companies…
Continue Reading
What You Should Know:
– Accenture has made a strategic investment, through Accenture Ventures, in 1910 Genetics, a biotechnology company revolutionizing drug discovery with its AI-powered platform. Terms of the investment were not disclosed.
– The…
Continue Reading
What You Should Know:
– Aignostics, a leading AI company specializing in pathology data analysis, raised $34M in Series B funding, led by ATHOS with participation from Mayo Clinic and growth financing from HTGF, alongisde…
Continue Reading
Software which enables computer-guided consultations is being rolled out to 150 GP practices across Greater Manchester, with the aim of supporting better adult asthma and chronic obstructive pulmonary disease (COPD) care.
The clinically-validated LungHealth solution…
What You Should Know:
– NaNotics LLC, a biopharmaceutical company developing NaNots® – novel subtractive nanoparticles that treat disease by capturing and clearing pathogenic molecules from blood – today announced that it has been selected for…
Continue Reading
What You Should Know:
– NaNotics LLC, a biopharmaceutical company developing NaNots® – novel subtractive nanoparticles that treat disease by capturing and clearing pathogenic molecules from blood – today announced that it has been selected for…
Continue Reading
What You Should Know:
– Gilead Sciences, a global biopharmaceutical company, and Genesis Therapeutics, an AI-focused biotechnology firm, have announced a strategic collaboration to discover and develop innovative small molecule therapies.
– The startegic partnership leverages…
Continue Reading
Biopharmaceutical company Pfizer is starting to serve consumers directly through its new telehealth platform called PfizerForAll, the company announced Tuesday. Pfizer declared that the platform is needed as consumers battle a confusing healthcare system.
PfizerForAll…
Continue Reading
